Abstract
Recently, we demonstrated that AgI can directly replace ZnII in zinc fingers (ZFs). The cooperative binding of AgI to ZFs leads to a thermodynamically irreversible formation of silver clusters destroying the native ZF structure. Thus, a reported loss of biological function of ZF proteins is a likely consequence of such replacement. Here, we report an X‐ray absorption spectroscopy (XAS) study of Ag n S n clusters formed in ZFs to probe their structural features. Selective probing of the local environment around AgI by XAS showed the predominance of digonal AgI coordination to two sulfur donors, coordinated with an average Ag−S distance at 2.41 Å. No Ag−N bonds were present. A mixed AgS2/AgS3 geometry was found solely in the CCCH AgI−ZF. We also show that cooperative replacement of ZnII ions with the studied Ag2S2 clusters occurred in a three‐ZF transcription factor protein 1MEY#, leading to a dissociation of 1MEY# from the complex with its cognate DNA.
Keywords: DNA Binding, Silver Clusters, Zinc Fingers, X-ray Absorption Spectroscopy
The cooperative AgI binding to CCHH zinc fingers causes zinc ion release followed by a collapse of the stable secondary structure and formation of a highly stable Ag2S2 cluster. CCHC, CCCH and CCCC zinc fingers react analogously. Such silver‐induced perturbation inhibits binding of the CCHH zinc finger protein to its cognate DNA sequence and as a consequence may affect many cellular processes including transcriptional regulation.

Introduction
Zinc finger (ZF) proteins play important roles in interactions with nucleic acids, other proteins, and even lipids to facilitate numerous biological processes. [1] The CCHH ZF motif is the most common one.[ 2 , 3 , 4 ] It is characterized by ZnII binding via highly conserved cysteinyl (Cys) and histidinyl (His) couples to stabilize the protein fold, further enhanced by conserved hydrophobic residues, which form a hydrophobic core during the metal‐coupled folding process. The resulting characteristic ββα fold guarantees spatial orientation of dedicated amino acid residues, enabling specific contacts with DNA sequences or structures (Figure 1A). The database of 131 CCHH ZF sequences available in 1991 encouraged J. Berg et al. to define the consensus ZF (consensus peptide 1, Cp‐1) by aligning these sequences and picking the most populated amino acid residues for each position. [5] The Cp‐1 sequence has been widely used as a model ZF in studies aimed at the understanding of kinetics and thermodynamics of metal‐coupled folding mechanisms, however CCHC, CCCH and CCCC ZF were also discovered.[ 6 , 7 , 8 ] Also, the data accumulation over the next 25 years empowered by new technologies produced 13 456 distinct CCHH ZF sequences by 2016, leading to the Cp‐1 sequence redefinition. [9]
Figure 1.
Structure and sequences of ZFs used in this study. A) 3D CCHH ZF fold adopted after ZnII binding derived from a crystal structure of the 1st ZF from designed Cp‐1‐like ZF protein (PDB: 1MEY). The residues shown in blue and green are key residues that bind to ZnII and form a hydrophobic core, respectively. Sequence‐specific DNA‐binding mode of the CCHH ZF is shown, and the key amino acids involved in interactions with DNA are highlighted in pink. B) Sequences of the Cp‐1 ZF (2015) variants investigated in this study. The metal binding amino acids and hydrophobic residues are highlighted in blue and green, respectively. C) The amino acid sequence of the ZF protein 1MEY ZFP aligned with a sequence of the ZFP used in this study 1MEY# ZFP. ZnII binding residues are highlighted in blue and hydrophobic residues are highlighted in green.
Many studies demonstrated that heavy metals may substitute ZnII in their native ZF coordination environment.[ 1 , 10 , 11 , 12 , 13 , 14 , 15 ] Such displacement induces conformational changes and alteration or loss of function. AgI ions have been vigorously tested for antimicrobial, anti‐inflammatory, or anticancer properties,[ 16 , 17 , 18 , 19 , 20 ] but their interactions with ZFs have been barely studied. [21] The use of elemental silver nanoparticles (AgNPs) is rising rapidly, and nowadays, 30 % of NP products are declared to contain AgNPs. Not only medical devices or bone implants but even daily use products, including cosmetics, bedding, sportswear, protective gear (such as masks heavily used during COVID‐19 pandemics), and food containers are coated with AgNPs for their antibacterial properties.[ 22 , 23 ] Rapid expansion of these coatings elevates the population exposure to AgNPs and AgI ions. Recently, high accumulation of silver in the liver and inhibition of hepatocyte nuclear receptors (NR) activity have been reported.[ 24 , 25 , 26 ] The silver reactivity with biomolecules is enabled by its high tendency to bind soft Lewis bases such as thiols, posing a question whether ZFs may be targets for AgI toxicity, e.g. by ZnII displacement. If so, what are biological consequences of such toxicity? Recently, we published a study of AgI binding to the redefined Cp‐1 CCHH ZF peptide and its sequence variations (CCCH and CCCC ZFs). [27] Using UV/Vis and CD spectroscopies, molecular dynamics calculations, and mass spectrometry (IM–MS), we demonstrated that AgI addition to these peptides resulted in ZnII dissociation and the ββα fold collapse. Various AgI−ZF complexes were detected, having the maximum number of bound AgI ions equal to the number of Cys residues in the ZF core (AgnSn sites), Ag2L, Ag3L, and Ag4L for Cp‐1 CCHH, CCCH, and CCCC ZFs, respectively. The AgI affinity for the respective complexes was at least hundred‐fold higher than that of ZnII. [27] These data lacked detailed structural information, however, and as far as we know, no other structural studies on AgI−ZF complexes have been reported. Herein, we have probed the AgI coordination environment in Cp‐1 ZFs (Figure 1B) using X‐ray absorption spectroscopy (XAS). XAS can selectively interrogate a chosen metal in a metalloprotein or metal complex, probe its average coordination sphere, and provide its bond lengths with high‐resolution (≈0.01 Å). The combined analysis of the near‐edge (XANES, X‐ray Absorption Near Edge Structure) and extended (EXAFS, Extended X‐ray Absorption Fine Structure) regions of the X‐ray absorption spectra provide the metal binding geometry, the nature of the ligands and the relative bond lengths, as well as the thermal and structural disorder.[ 28 , 29 , 30 , 31 , 32 , 33 , 34 ] Therefore, herein, we used XAS to evaluate the formation of multinuclear Ag n S n clusters in Cp‐1 ZFs and to gain direct insight into their structure. Furthermore, we used electronic spectroscopy techniques and gel electrophoresis to study the impact of AgI ions on the DNA complex of 1MEY# ZF protein (ZFP) (Figure 1C).
Results and Discussion
Qualitative Observation of XAS Spectra
The silver K‐edge XAS spectra were collected from ZF samples saturated with AgI ions (AgI−ZFs), thus containing 2 molar equivalents of AgI for the CCHH ZF, 3 equivalents for CCHC and CCCH ZFs, and 4 equivalents for the CCCC ZF (see: Materials and Methods). These metal to ZF stoichiometric ratios were established by CD, as reported previously. [27] The XANES spectra of AgI−ZFs and the reference AgI glutathione complex (AgI−GSH) are reported in Figure S1. The XANES region shows nearly identical spectral features for all examined AgI−ZFs, suggesting only small variations in the AgI coordination environments among them. The k3‐weighted EXAFS spectra of AgI−ZF complexes are shown in Figure 2A, along with the corresponding Fourier transform (FT) in Figure 2B. The best fitting curves are reported in red over the corresponding experimental spectra (black curves), both in the reciprocal space (Figure 2A) and in the real space (Figure 2B). All FT spectra show two main peaks centered at 2.0 Å and 2.8 Å, probably originating from single‐scattering contributions of two atomic shells. In all studied AgI−ZF samples, the first‐shell peak is narrow and centered at around 2.0 Å, closely resembling the one observed in the AgI−GSH reference complex featuring a digonal AgS2 coordination (Figure S2). Furthermore, the peak observed at about 2.8 Å in the FT spectra might indicate the presence of the second shell of AgI atoms forming a non‐bonding Ag⋅⋅⋅Ag interactions with the absorber, as previously described in the AgI−GSH complex. [35] A small contribution centered at 1.4 Å (Figure 2B) also present in all spectra might be due either to the presence of N or O ligands in the AgI coordination sphere, or to the window used to Fourier‐transform the spectra. The ab initio analysis of the spectra was necessary to define the number and nature of the AgI ligands, and the interatomic distances.
Figure 2.

Experimental XAS data. A) K‐edge EXAFS spectra of silver fingers (black) together with the relative best‐fitting curves (red) obtained in the real space, then back‐transformed into the reciprocal space. B) Fourier‐transformed experimental EXAFS spectra (black) and the relative best‐fitting curves (red) obtained from least‐squares minimization of spectra generated with ab initio calculations.
Ab Initio EXAFS Analysis
In order to determine the AgI−S coordination geometries, the FT spectra were fitted with a simple model including a first shell of S and N or O nearest neighbors, and a second shell of Ag atoms around the absorber. The best‐fitting parameters are reported in Table 1; the FT spectra for the best‐fitting curves together with the corresponding experimental data are shown in Figure 2B. As a template, we measured the spectrum of an AgI−GSH complex (Figure S2B) formed in solution with 1 equivalent AgI, corresponding to 1 AgI per Cys residue. In these conditions, AgI−GSH forms mononuclear digonal AgS2 species, as proved by XRD and XAS studies.[ 35 , 36 , 37 ] Therefore, we measured empirically the amplitude reduction spectrum, by fixing the coordination number to two and allowing S0 2 to vary. The estimated value of 0.79±0.04 was then fixed over the analysis of all AgI−ZF samples, in which the coordination numbers were allowed to vary. The best‐fitting distances and DW factors of AgI−GSH (Table 1) were used as starting values for all AgI−ZF samples. The fits were performed in the real space, initially in the R range 1.0 to 2.3 Å, including only first‐shell Ag−S and Ag−N or Ag−O scattering contributions. The number of S (nS) and N/O (nN/O) atoms were allowed to vary: nN/O was always estimated as 0 within the error, allowing us to exclude the presence of His nitrogen atoms or water molecules as AgI donors. The fitting range was then adjusted to [1.4–3.1] Å, in order to include the two main atomic shells around the absorber. The number of S donors and Ag−S distances (Table 1) are consistent with those reported in literature for digonal AgS2 sites in inorganic and biological AgI complexes.[ 31 , 32 , 33 , 36 , 37 ] For the CCCH AgI−ZF, however, the number of sulfur atoms was estimated as 2.4±0.2 at 2.442±0.004 Å. A recent survey reported an average Ag−S distances of 2.39±0.03 Å in AgS2 thiolate sites, and of 2.51±0.05 Å in AgS3 sites. [36] Based on that, the average Ag−S distance found in CCCH ZF cannot be unequivocally assigned to either AgS2 or AgS3 coordination. Instead, this distance is in very good agreement with that observed for mixed AgS2/AgS3 sites in metallothionein. [34] For all complexes, we observed less than 1 Ag atom at ≈2.99 Å from the absorber (Table 1). The agreement between experimental and theoretical curves is excellent, as confirmed by low goodness‐of‐fit indexes (Rfit factor) reported in Table 1, both in the real space (Figure 2B) and in the reciprocal space (Figure 2A). The estimated Ag−Ag distances indicate the formation of non‐bonding Ag⋅⋅⋅Ag interactions similar to those found in Ag(HPen)⋅H2O. [37]
Table 1.
Best‐fit parameters obtained from the analysis of the EXAFS spectra of AgI−GSH and AgI−ZF complexes.
|
|
Ag−S |
Ag−Ag |
Fit parameters |
|||||
|---|---|---|---|---|---|---|---|---|
|
n [b] |
R [Å][c] |
σ 2 [×10−3 Å2][d] |
n [b] |
R [Å][c] |
σ 2 [×10−3 Å2][d] |
ΔE 0 [eV][e] |
R fit [%][f] |
|
|
GSH |
2.0[a] |
2.408(5) |
3.1(7) |
0.8(4) |
2.98(2) |
9(5) |
2.5(6) |
0.5 |
|
CCCC ZF |
2.0(1) |
2.416(3) |
3.5(3) |
0.7(2) |
2.99(1) |
8(1) |
3.8(3) |
0.3 |
|
CCHH ZF |
2.0(1) |
2.404(4) |
3.0(3) |
0.3(2) |
2.99(3) |
6(3) |
3.2(4) |
0.4 |
|
CCHC ZF |
2.0(3) |
2.424(6) |
4.8(5) |
0.7(3) |
2.98(2) |
7(2) |
3.5(5) |
1.0 |
|
CCCH ZF |
2.4(2) |
2.443(4) |
6.3(4) |
0.9(3) |
3.00(1) |
6(1) |
3.1(4) |
0.5 |
Overall, a simple two‐shells single‐scattering model allowed for a very good reproduction of the experimental signals, as confirmed also by the observation of the fitting curves back‐transformed and overlapped to the experimental data in the reciprocal space (Figure 2B). These XAS data prompted us to propose the structures of Ag n S n clusters in AgI−ZFs (Figure 3A), generally consistent with our previously reported models obtained by quantum mechanics/molecular mechanics (QM/MM) and molecular dynamics simulations (presented in Figure 3B for a comparison). [27] The average Ag−S bond length of the CCCH AgI−ZF is longer than in other AgI−ZFs. As a result, the AgI−thiolate cluster in this particular ZF tends to form a more twisted‐chain structure, probably inducing minor changes in the secondary structure as a whole (also indicated by CD, see below).
Figure 3.
Structural features of AgI−ZFs. A) Proposed structure of AgnSn ZF clusters probed in this study by EXAFS analysis. Each cysteine residue is numbered in accordance with ZF sequences from Figure 1B. B) Model structures of AgnSn ZF clusters obtained by QM/MM MD‐based simulations.[27] C and N denote the C‐ and N‐terminal end of ZFs, respectively.
Relationship between the AgI Coordination Environment and Structures of AgI−ZFs CCCH and CCHC.
Because EXAFS data revealed differences in AgI coordination geometry between CCCH ZF and CCHC ZF, we decided to monitor the AgI binding to CCHC ZF (which was not studied before) using CD spectroscopy, to see if differences in AgI−thiolate cluster geometries in the respective AgI−ZFs could affect the folding process. The 0 to 4 equivalents of AgI were titrated to the CCHC ZF. The resulting CD spectra (Figure 4) featured various negative and positive bands in the 200–250 nm range indicating the formation of multiple AgI complexes. As shown in Figure 4A, the CD band at 245 nm (+, weak) occurred around 2 equivalents of AgI; and was replaced between 2 and 3 equivalents by bands at 205 nm (−, moderate) and 220 nm (−, moderate). No spectral changes occurred above 3 equivalents of AgI. The signal at 245 nm originates from S→AgI LMCT, while signals at 200–230 nm are mostly due to secondary structure features. Similarly, the band at 245 nm was previously reported for the CCHH, CCCH and CCCC ZFs. [27] Its maximum intensity was observed at exactly 2 equivalents of AgI for all studied ZFs, and hence was assigned to the Ag2S2 cluster formation. Such clusters may be formed in several ways, including interpeptide complexes. Nevertheless, the results presented here are consistent with a transition from the Ag2S2 cluster to the Ag3S3 cluster between 2 and 3 equivalents of AgI during titration of CCHC ZF with a parallel secondary structure alteration. [38] An isodichroic point at 227 nm present at 2 mol equivalents of AgI is blue shifted to 210 nm for 3 mol equivalents of AgI (Figure 4, black arrows), indicative of a β‐structure‐coil transition. [39] Therefore, the movement of the isodichroic point along the formation of AgI−thiolate clusters can be related to a subsequent secondary structure transition. Similarly to the previously studied CCCH AgI−ZF, the maximal number of AgI ions bound to CCHC ZF was equal to the number of Cys residues, yielding a Ag3L stoichiometry. Interestingly, the CD spectra obtained herein for the CCHC AgI−ZF differed slightly from those reported previously for the CCCH AgI‐ZF at 3 mol equivalents of AgI (Figure 4B), indicating a secondary structure difference. [27] To further probe the CD bands at 200–260 nm in the saturated AgI complex, the differential spectra of the tested peptides were included in Figure 4C and 4D. For that purpose the metal‐free ZF spectrum was subtracted from the AgI‐saturated ZF peptide spectrum. Because metal‐free ZF spectrum adopts a random coil structure, the contribution between 200–230 nm derived from the intrinsic chirality of the component amino acids was subtracted. Such differential CD spectrum is solely derived from the AgI‐bound peptide chain, containing contributions from the peptide fold (secondary structure) and thiolate (or imidazole) to AgI LMCT bands. Therefore, the differential spectra are not the clear‐cut indicators of secondary structure formation. Nevertheless, taking into account conserved sequences of both peptides and the same number of Cys and His ligands, we can conclude that the differences between these spectra reflect secondary structure differences. The AgS2 site in CCHC ZF induced the formation of a positive signal at 210 nm and a negative one at 220 nm, corresponding to a combination of random coil and β‐elements (Figure 4C). Its differential spectrum resembles those obtained elsewhere for CCHH AgI−ZF (Figure S3A). [27] The mixed AgS2/AgS3 site in CCCH ZF induced the partial formation of α‐ and β‐elements, as proved by negative signals at 210 nm and 220 nm (Figure 4D), similar to those observed for the CCCC AgI−ZF cluster with a ββα fold (Figure S3B). [27] This shows that relationship between Cys residues positions and the arrangement of the silver coordination site will contribute to secondary structural elements.
Figure 4.

CD titrations of 25 μM metal‐free A) CCHC ZF (examined in this study) and B) CCCH ZF (data obtained previously) [27] in 20 mM TES buffer (pH 7.0) with AgNO3 solution. The light blue, green, dark blue, magenta, and black lines indicate 0, 1, 2, 3, and 4 equivalents of added AgI, respectively. Arrows indicate observable isodichroic points. The insets represent the CD signal at 245 nm as a function of the AgI‐to‐ZF molar ratio. C) and D) the differential spectra obtained by subtraction of metal‐free CCHC and CCCH ZF CD spectrum from fully AgI‐loaded CCHC and CCCH ZF spectrum, respectively. The dotted lines represent ellipticity changes at 210 and 220 nm.
Impact of AgI Ions on ZF‐DNA Interaction
In order to look deeper into the toxicological consequences of the formation of AgI−thiolate clusters in a ZFP, we performed a CD‐based AgI titration of the ZnII‐saturated 1MEY# ZFP[ 40 , 41 ] (holo‐protein consisting of three finger domains) and its DNA complex. The 1MEY# ZF holo‐protein exhibited characteristic negative bands at 205 nm and 225 nm (Figure 5A), indicating the ββα structure formation. This well‐defined structure of the CCHH zinc fingers in the holo‐protein collapsed gradually upon the addition of AgI ions as indicated by the CD spectra presented in Figure 5A. The finger units seem to behave independently, as suggested by the isodichroic point at 204 nm. The CD spectrum changed by increasing the AgI excess up to ≈2 AgI equivalents per ZF (up to ≈6 equiv AgI per protein). The final CD spectrum of the AgI‐saturated 1MEY# ZFP (Figure 5A) is very similar to the spectrum recorded for 1MEY# ZFP demetalated by the EDTA excess (green dotted line, Figure 5A). To confirm the ZnII release from 1MEY# ZFP by the AgI binding, the chromophoric ZnII chelating probe 4‐(2‐pyridylazo)resorcinol (PAR) was added to the holo‐protein, followed by stepwise addition of AgI ions, up to 12 per protein. Monitoring the ZnII dissociation from 1MEY# ZFP is possible due to the formation of a ZnH x (PAR)2 complex intensely absorbing light at 492 nm (ϵ=71 500 M−1 cm−1). [42] The AgI complex of PAR does not absorb at 492 nm, as reported, [27] thus enabling a direct ZnII dissociation quantitation. Titrations of 1MEY# ZF holo‐protein with AgI in the presence of a PAR excess yielded a clear endpoint at ca. 6 equivalents of AgI, based on four independent titrations (Figure 5B), in perfect accordance with an expectation of complete ZnII displacement from CCHH ZFs by the formation of Ag2S2 clusters (Figure 3A). Together with the CD titration data, this result indicates that ZnII ions can be completely displaced from ZFPs during AgI overload, accompanied by a loss of three‐dimensional ZFP ββα structure. To further explore possible biological implications of this finding, the DNA binding of 1MEY# ZF holo‐protein in the presence of AgI was also studied. CD spectroscopy revealed that the addition of cognate S1 DNA to the holo‐protein enhanced the intensity of CD bands as compared to the curve calculated by summing up the component spectra of 1MEY# ZFP and S1 DNA in the appropriate ratio (Figure 5C). This indicated the formation of a tight ZFP‐DNA complex. Nevertheless, the addition of ≈6 equivalents of AgI per protein resulted in a significant decrease of the CD spectral intensity, down to the calculated value assuming no protein DNA interaction (Figure 5C) suggesting that the AgI ions could efficiently compete for 1 MEY#ZFP with DNA. This result was further supported by an electrophoretic mobility shift assay (EMSA) in a native polyacrylamide gel. Figure 5D shows how in the AgI absence, the 1MEY# ZFP binds its cognate S1 DNA, increasing its apparent size from the original 34 bp to ca. 50 bp. Upon the AgI addition, the expected gradual DNA release occurred. At 6 AgI equivalents (2 equiv per ZF motif), the gel mobility shift vanished, and only the original DNA band was visible in the gel at 34 bp. As demonstrated in Figure 5E, the sigmoidal pattern of the of ZFP‐free DNA band intensity increase with AgI suggests a cooperative mechanism of AgI binding to ZFPs. Hypothetically, the replacement of one ZnII ion with the Ag2S2 cluster destabilizes the ZFP‐DNA interaction, facilitating the AgI assault on the other two ZFs. These experiments indicate a strong ability of AgI ions to prevent the interaction of the CCHH type ZFPs with DNA at a 2 : 1 AgI to ZF motif ratio under the applied conditions.
Figure 5.
AgI binding to CCHH 1MEY# ZFP and damage of ZF structure and DNA‐ZFP complex. A) CD titration of 16 μM ZnII‐loaded 1MEY# ZFP with AgI in 10 mM HEPES buffer pH 7.4. The arrow represents the increasing equivalents of added AgI. The dotted green line represents the CD spectrum of 1MEY# ZFP at a 5‐fold excess of EDTA. The isodichroic point zoomed in the inset is marked with a black arrow. B) ZnII transfer from 2.5 μM 1MEY# ZFP to 89 μM PAR during a titration with 0–12 equivalents of AgI. The measurement was performed in 50 mM HEPES buffer (pH 7.4). Inset indicates that six AgI ions are bound to 1MEY# ZFP (two AgI per each ZF motif) and three ZnII are dissociated. C) Comparison of the CD spectra obtained for the equimolar (12–12 μM) mixtures of ZnII‐saturated 1MEY# ZFP and specific S1 DNA in the presence and absence of 6 equivalents of AgI in 10 mM HEPES, 90 mM NaClO4 buffer (pH 7.4). The dotted lines represent the CD spectra calculated by summing the appropriate protein and DNA component spectra. The applied 6 equivalents of AgI (2 equiv of AgI per each ZF unit) destroyed the 1MEY# ZFP structure. D) Electrophoretic gel mobility shift assay of 1MEY# ZFP with the specific S1 DNA probe in the presence of increasing equivalents of AgI indicates that 6 equivalents of AgI per 1MEY# ZFP (2 equiv per each ZF unit) results in a complete dissociation of 1MEY# ZFP‐DNA complex. A 0.25 eq. protein excess was applied over S1 DNA in 10 mM HEPES, 150 mM NaClO4 buffer (pH 7.4). E) Distribution of S1 DNA along with the AgI titration of ZFP‐DNA complex. The fractions of ZFP‐bound and free DNA were calculated based on the intensities of five independent electrophoretic gel mobility shift assays. Band intensity calculations were performed by ImageJ. [43] Deviation of AgI/ZFP ratios from experiment to experiment varied by less than 2 %. Therefore, these error bars are not presented as they would be fully contained within the symbols. The same regards the DNA fractions for AgI/ZFP ratios of 7 and 8. F) Schematic representation of consequences of AgI binding to 1MEY ZFP complexed with DNA (PDB: 1MEY).
The results presented above demonstrated that all major ZF types can be targeted by AgI ions in physiological conditions, which results in the loss of their native three‐dimensional structure. The replacement of ZnII in ZFs by AgI‐thiolate clusters described in detail in this study will thus disable the physiological functions of ZFPs, which are based on molecular recognition empowered by native ZF conformations. This was demonstrated directly here, by observing the AgI‐dependent detachment of 1MEY# ZFP, bearing three CCHH ZF domains, from its cognate DNA (Figure 5D–F). Our findings indicate that AgI ions, including those released intracellularly from AgNPs may interfere with a manifold of cellular processes involved in gene expression, genomic integrity, cell growth, differentiation, and DNA repair.
Conclusion
The knowledge regarding ZnII substitution in proteins by other metal ions is critical for the assessment of possible toxicological consequences of such chemical reactions. The ZnII replacement by another metal ion may lead to the formation of stronger metal complexes with disturbed coordination geometry and/or unwanted chemical reactivity. Silver nanoparticles (AgNPs) are widely present in the human environment, enabling Ag0 and AgI bioavailability. Once in the cell cytosol, they end up as AgI−thiolate complexes suggesting that cysteine‐rich proteins and peptides are their preferred biological targets. Herein, we characterized in detail the structures of AgI complexes in sequentially diverse ZFs, highlighting a formation of Ag n S n clusters (n=2, 3 or 4) with the predominant AgS2 binding mode. The average Ag−S bond lengths for CCHH, CCHC, and CCCC ZFs are in good agreement with average Ag−S bond lengths for Ag−thiolate clusters reported previously. We also showed that the loss of native ZFP chain conformation caused by ZnII replacement with AgI directly destroyed the specific DNA binding by a three ZF array 1MEY# ZFP. In conclusion, our findings provide strong chemical evidence for the genotoxic potential of silver and lay a solid foundation for further research on silver toxicity.
Conflict of interest
The authors declare no conflict of interest.
1.
Supporting information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supporting Information
Acknowledgements
This research was supported by the National Science Centre of Poland (NCN) under Opus and Preludium grants No. 2019/33/B/ST4/02428 (to A. K.) and 2019/33/N/ST4/00409 (to K.K.), by the Hungarian National Research, Development and Innovation Office (GINOP‐2.3.2‐15‐2016‐00038 and K_16/120130), and by a POLONIUM grant to W.B. and A.D. The authors would like to thank Manuel D. Peris‐Díaz for sharing his MD results on Ag n S n clusters. [26] The authors acknowledge the European Synchrotron Radiation Facility for provision of synchrotron radiation facilities (project LS‐2967) and thank Isabelle Kieffer for assistance in using the beamline BM30. The support of SRCD measurements from the CALIPSOplus (EU Framework Programme for Research and Innovation HORIZON 2020, grant no. 730872) is also greatly acknowledged.
K. Kluska, G. Veronesi, A. Deniaud, B. Hajdu, B. Gyurcsik, W. Bal, A. Krężel, Angew. Chem. Int. Ed. 2022, 61, e202116621; Angew. Chem. 2022, 134, e202116621.
Contributor Information
Prof. Wojciech Bal, Email: wbal@ibb.waw.pl.
Prof. Artur Krężel, Email: artur.krezel@uwr.edu.pl.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
- 1. Kluska K., Adamczyk J., Krężel A., Coord. Chem. Rev. 2018, 367, 18–64. [Google Scholar]
- 2. Klug A., Annu. Rev. Biochem. 2010, 79, 213–231. [DOI] [PubMed] [Google Scholar]
- 3. Andreini C., Bertini B. L., Rosato A., J. Proteome Res. 2006, 5, 196–201. [DOI] [PubMed] [Google Scholar]
- 4. Matthews J. M., Sunde M., IUBMB Life 2002, 54, 351–355. [DOI] [PubMed] [Google Scholar]
- 5. Krizek B. A., Amann B. T., Kilfoil V. J., Merkle D. L., Berg J. M., J. Am. Chem. Soc. 1991, 113, 4518–4523. [Google Scholar]
- 6. Krizek B. A., Merkle D. L., Berg J. M., Inorg. Chem. 1993, 32, 937–940. [Google Scholar]
- 7. Blasie C. A., Berg J. M., Biochemistry 2002, 41, 15068–15073. [DOI] [PubMed] [Google Scholar]
- 8. Quintal S. M., dePaula Q. A., Farrell N. P., Metallomics 2011, 3, 121–139. [DOI] [PubMed] [Google Scholar]
- 9. Besold A. N., Widger L. R., Namuswe F., Michalek J. L., Michel S. L. J., Goldberg D. P., Mol. BioSyst. 2016, 12, 1183–1193. [DOI] [PubMed] [Google Scholar]
- 10. Payne J. C., Ter Horst M. A., Godwin H. A., J. Am. Chem. Soc. 1999, 121, 6850–6855. [Google Scholar]
- 11. Bal W., Schwerdtle T., Hartwig A., Chem. Res. Toxicol. 2003, 16, 242–248. [DOI] [PubMed] [Google Scholar]
- 12. Kopera E., Schwerdtle T., Hartwig A., Bal W., Chem. Res. Toxicol. 2004, 17, 1452–1458. [DOI] [PubMed] [Google Scholar]
- 13. Grosskopf C., Schwerdtle T., Mullenders L. H., Hartwig A., Chem. Res. Toxicol. 2010, 23, 1175–1183. [DOI] [PubMed] [Google Scholar]
- 14. Du Z., de Paiva R. E. F., Nelson K., Farrell N. P., Angew. Chem. Int. Ed. 2017, 56, 4464–4467; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2017, 129, 4535–4538. [Google Scholar]
- 15. Heinz U., Hemmingsen L., Kiefer M., Adolph H. W., Chemistry 2009, 15, 7350–7358. [DOI] [PubMed] [Google Scholar]
- 16. Eckhardt S., Brunetto P. S., Gagnon J., Priebe M., Giese B., Fromm K. M., Chem. Rev. 2013, 113, 4708–4754. [DOI] [PubMed] [Google Scholar]
- 17. Bhol K. C., Schechter P. J., Dig. Dis. Sci. 2007, 52, 2732–2742. [DOI] [PubMed] [Google Scholar]
- 18. Allison S. J., Sadiq M., Baronou E., Cooper P. A., Dunnill C., Georgopoulos N. T., Latif A., Shepherd S., Shnyder S. D., Stratford I. J., Wheelhouse R. T., Willans C. E., Phillips R. M., Cancer Lett. 2017, 403, 98–107. [DOI] [PubMed] [Google Scholar]
- 19. Wang H., Wang M., Yang X., Xu X., Hao Q., Yan A., Hu M., Lobinski R., Li H., Sun H., Chem. Sci. 2019, 10, 7193–7199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Wang H., Yan A., Liu Z., Yang X., Xu Z., Wang Y., Wang R., Koohi-Moghadam M., Hu L., Xia W., Tang H., Wang Y., Li H., Sun H., PLoS Biol. 2019, 17, e3000292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Park G., Amaris Z. N., Eiken M. K., Baumgartner K. V., Johnston K. A., Williams M. A., Marckwordt J. G., Millstone J. E., Splanc K. E., Wheeler K. E., Environ. Sci. Nano 2019, 6, 2367–2378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Bapat R. A., Chaubal T. V., Joshi C. P., Bapat P. R., Choudhury H., Pandey M., Gorain M., Kesharwani P., Mater. Sci. Eng. 2018, 91, 881–898. [DOI] [PubMed] [Google Scholar]
- 23. Betts H. D., Neville S. L., McDevitt C. A., Sumby C. J., Harris H. H., J. Inorg. Biochem. 2021, 225, 111598. [DOI] [PubMed] [Google Scholar]
- 24. Marchioni M., Jouneau P. H., Chevallet M., Michaud-Soret I., Deniaud A., Coord. Chem. Rev. 2018, 364, 118–136. [Google Scholar]
- 25. Tardillo Suárez V., Karepina E., Gallet B., Cottet-Rousselle C., Chevallet M., Charbonnier P., Moriscot C., Michaud-Soret I., Bal W., Fuchs A., Tucoulou R., Jouneau P. H., Veronesi G., Deniaud A., Environ. Sci. Nano 2020, 7, 1373–1387. [Google Scholar]
- 26. Poznański J., Sołdacki D., Czarkowska-Pączek B., Bonna A., Kornasiewicz O., Krawczyk M., Bal W., Pączek L., Int. J. Mol. Sci. 2021, 22, 1782–1793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Kluska K., Peris-Díaz M. D., Płonka D., Moysa A., Dadlez M., Deniud A., Bal W., Krężel A., Chem. Commun. 2020, 56, 1329–1332. [DOI] [PubMed] [Google Scholar]
- 28. Navaratnam S., Myles G. M., Strange R. W., Sancar R. W., J. Biol. Chem. 1989, 264, 16067–16071. [PubMed] [Google Scholar]
- 29. Diakun G. P., Fairall L., Klug A., Nature 1986, 324, 698–699. [DOI] [PubMed] [Google Scholar]
- 30. George G. N., Winge D., Stout C. D., Cramer S. P., J. Inorg. Biochem. 1986, 27, 213–220. [DOI] [PubMed] [Google Scholar]
- 31. Hess N. J., Buchko G. W., Conradson S. D., Espinosa F. J., Ni S., Thrall B. D., Kennedy M. A., Protein Sci. 1998, 7, 1970–1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Gui Z., Green A. R., Kasrai M., Bancroft G. M., Stillman M. J., Inorg. Chem. 1996, 35, 6520–6529. [DOI] [PubMed] [Google Scholar]
- 33. Kawai T., Konishi T., Fujikawa T., Sekine A., Imai L. F., Akama K., J. Synchrotron Radiat. 2001, 8, 993–995. [DOI] [PubMed] [Google Scholar]
- 34. Veronesi G., Gallon T., Deniaud A., Boff B., Gateau C., Lebrun C., Vidaud C., Rollin-Genetet F., Carrière M., Kieffer I., Mintz E., Delangle P., Michaud-Soret I., Inorg. Chem. 2015, 54, 11688–11696. [DOI] [PubMed] [Google Scholar]
- 35. Veronesi G., Aude-Garcia C., Kieffer I., Gallon T., Delangle P., Herlin-Boime N., Rabilloud T., Carrière M., Nanoscale 2015, 7, 7323–7330. [DOI] [PubMed] [Google Scholar]
- 36. Veronesi G., Deniaud A., Gallon T., Jouneau P. H., Villanova J., Delangle P., Carriere M., Kieffer I., Charbonnier P., Mintz E., Michaud-Soret I., Nanoscale 2016, 8, 17012–17021. [DOI] [PubMed] [Google Scholar]
- 37. Leung B. O., Jalilehvand F., Mah V., Parvez M., Wu Q., Inorg. Chem. 2013, 52, 4593–4602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Zelazowski A. J., Gasyna Z., Stillman M. J., J. Biol. Chem. 1989, 264, 17091–17099. [PubMed] [Google Scholar]
- 39. Maeda H., Ooi K., Biopolymers 1981, 20, 1549–1563. [Google Scholar]
- 40. Kim C. A., Berg J. M., Nat. Struct. Mol. Biol. 1996, 3, 940–945. [DOI] [PubMed] [Google Scholar]
- 41. Belczyk-Ciesielska A., Csipak B., Hajdu B., Sparavier A., Asaka M. N., Nagata K., Gyurcsik B., Bal W., Metallomics 2018, 10, 1089–1098. [DOI] [PubMed] [Google Scholar]
- 42. Kocyła A., Pomorski A., Krężel A., J. Inorg. Biochem. 2015, 152, 82–92. [DOI] [PubMed] [Google Scholar]
- 43. Schneider C. A., Rasband W. S., Eliceiri K. W., Nat. Methods 2012, 9, 671–675. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supporting Information
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.



